Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 199

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence

Open access
DESREUMAUX, P., GHOSH, S.·2006·Alimentary Pharmacology & Therapeutics

Abstract

Summary: The effectiveness of sulfasalazine depends on the splitting of the diazo bond in the molecule by the action of bacteria in the large bowel, releasing the pharmacologically active moiety, 5‐aminosalicylic acid. The development of pH‐dependent, delayed‐release formulations of 5‐aminosalicylic acid abolished the toxicity associated with the sulfapyridine part of sulfasalazine. 5‐aminosalicylic acid is now believed to act by activating a class of nuclear receptors involved in the control of inflammation, cell proliferation, apoptosis and metabolic function, the γ form of peroxisome proliferator‐activated receptors. These receptors are expressed at particularly high levels in colon epithelial cells, where their expression appears to be at least in part stimulated by gut bacteria. Other drugs known to act via peroxisome proliferator‐activated receptor‐γ, such as rosiglitazone and the selective peroxisome proliferator‐activated receptor‐γ ligand GW1929, can be displaced from their binding sites on the peroxisome proliferator‐activated receptor‐γ molecule by 5‐aminosalicylic acid at concentrations of 5‐aminosalicylic acid that correspond with the concentrations found in the lumen of ulcerative colitis patients taking oral mesalazine. Genetically engineered heterozygous knockout mice (peroxisome proliferator‐activated receptor‐γ±) are particularly susceptible to colonic inflammation, and inflammation is more severe in these mice, in response to chemicals that induce experimental colonic ulcers. In these experimental models, 5‐aminosalicylic acid is ineffective in peroxisome proliferator‐activated receptor‐γ± mice. This new insight provides a mechanistic foundation for the possibility that long‐term treatment with 5‐aminosalicylic acid can reduce the risk of colorectal cancer in patients with ulcerative colitis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2006.03069.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 199

Metadata

Authors
DESREUMAUX, P., & GHOSH, S.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2006-08-22
Volume
24
Issue
s1
Pages
2-9
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2062854941
Cited by
199
References
1
FWCI
6.01
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence. https://app.cochat.ai/papers/10.1111/j.1365-2036.2006.03069.x
The paper
DESREUMAUX, P., & GHOSH, S. (2006). Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2006.03069.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.